Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

The treatment was effective for advanced non-Hodgkin's lymphomas.

CMV infection increases the risk of GvHD after bone marrow transplants.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The assay effectively identifies compounds that affect immune cell activation.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

The role of γδT-cells in causing alopecia areata remains unclear.

Tph cells are linked to the severity of systemic lupus erythematosus.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.